Cantor Fitzgerald Reiterates a 'Buy' on Brocade (BRCD); Frankly...We Expect A Lot; Strategic Suitor Questionable
Tweet
Share
E-mailGet Alerts BRCD Hot Sheet
Price: $12.73 --0%
Rating Summary:
4 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
4 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Cantor Fitzgerald reiterates a 'Buy' on Brocade (NASDAQ: BRCD) price target of $7.00 (from $6.00).
Analyst, Paul Mansky, said, "We expect market share gains in Fibre Channel, better execution in Ethernet, and rapidly improving balance sheet to be catalysts for reduced investor apathy over the coming year."
"The case for a strategic suitor is still questionable. However, we view the recent management/board transition, an activist owner at 9.2% (not un-related) and the proposed sale/lease-back as making the case for privatization incrementally attractive. If this were to transpire, we would view EV/Sales of 2.0x as reasonable, or $9-10."
For an analyst ratings summary and ratings history on Brocade click here. For more ratings news on Brocade click here.
Shares of Brocade closed at $5.88 yesterday.
Analyst, Paul Mansky, said, "We expect market share gains in Fibre Channel, better execution in Ethernet, and rapidly improving balance sheet to be catalysts for reduced investor apathy over the coming year."
"The case for a strategic suitor is still questionable. However, we view the recent management/board transition, an activist owner at 9.2% (not un-related) and the proposed sale/lease-back as making the case for privatization incrementally attractive. If this were to transpire, we would view EV/Sales of 2.0x as reasonable, or $9-10."
For an analyst ratings summary and ratings history on Brocade click here. For more ratings news on Brocade click here.
Shares of Brocade closed at $5.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Terreno Realty Corp (TRNO) PT Raised to $77 at Cantor Fitzgerald on Leasing Optimism
- MiMedx Group (MDXG) Reiterated at Overweight by Cantor Fitzgerald: Wound Care Market Stable
- Agios Pharma (AGIO) Reiterated at Overweight by Cantor Fitzgerald on Thalassemia Opportunity
Create E-mail Alert Related Categories
Analyst Comments, Rumors, Trader TalkRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
